Board reasoning
The Board remanded all claims to obtain additional etiological opinions and to clarify whether topical skin therapy constitutes systemic therapy, citing prior remand directives and Stegall v. West to justify continued remand. The decision emphasizes intertwined issues and the need for ACE opinions without in-person examination, and notes repeated non-compliance with remand orders, but continues to remand rather than grant or deny the claims.
Issues
- hypertensionRemanded
- tinea versicolor (initial increased rating)Remanded
- TDIU (effective date prior to Sept 27, 2011)Remanded
Extracted with gpt-5-nano-2025-08-07. Citations are kept only when they appear in the decision text.